Literature DB >> 24925943

Using nitrofurantoin while breastfeeding a newborn.

Jamie Zao, Gideon Koren, Pina Bozzo.   

Abstract

QUESTION: My patient has a urinary tract infection and is currently breastfeeding. Her son is only 3 weeks old. Is nitrofurantoin a safe antibiotic for treatment? ANSWER: The use of nitrofurantoin in breastfeeding mothers is generally safe, as only small amounts transfer into the breast milk. Despite the lack of documented reports, there is a risk of hemolytic anemia in all newborns exposed to nitrofurantoin owing to their glutathione instability, especially in infants with glucose-6-phosphate dehydrogenase deficiency. Although some suggest that nitrofurantoin be avoided in infants younger than 1 month, studies have noted that glutathione stability might be established by the eighth day of life. In infants younger than 1 month, an alternative antibiotic might be preferred; however, if an alternative were not available, the use of nitrofurantoin would not be a reason to avoid breastfeeding. In any such case the suckling infant should be monitored by his or her physician. Copyright© the College of Family Physicians of Canada.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24925943      PMCID: PMC4055319     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  13 in total

1.  An in-vitro abnormality of glutathione metabolism in erythrocytes from normal newborns: mechanism and clinical significance.

Authors:  W H ZINKHAM
Journal:  Pediatrics       Date:  1959-01       Impact factor: 7.124

2.  The pentose phosphate pathway in human erythrocytes; relationship between the age of the subject and enzyme activity.

Authors:  R T GROSS; R E HURWITZ
Journal:  Pediatrics       Date:  1958-09       Impact factor: 7.124

3.  Glutathione metabolism in cord and newborn infant blood.

Authors:  A SZEINBERG; B RAMOT; C SHEBA; A ADAM; I HALBRECHT; M RIKOVER; S WISHNIEVSKY; E RABAU
Journal:  J Clin Invest       Date:  1958-10       Impact factor: 14.808

4.  Active transport of nitrofurantoin into human milk.

Authors:  P M Gerk; R J Kuhn; N S Desai; P J McNamara
Journal:  Pharmacotherapy       Date:  2001-06       Impact factor: 4.705

5.  The excretion of orally ingested nitrofurantoin in human milk.

Authors:  I Varsano; J Fischl; S B Shochet
Journal:  J Pediatr       Date:  1973-05       Impact factor: 4.406

Review 6.  Hemolytic reactions to nitrofurantoin in patients with glucose-6-phosphate dehydrogenase deficiency: theory and practice.

Authors:  J E Gait
Journal:  DICP       Date:  1990-12

7.  Absence of nitrofurantoin from human milk.

Authors:  R H Hosbach; R B Foster
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

8.  Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication.

Authors:  S Ito; A Blajchman; M Stephenson; C Eliopoulos; G Koren
Journal:  Am J Obstet Gynecol       Date:  1993-05       Impact factor: 8.661

9.  Nitrofurantoin excretion in human milk.

Authors:  G Pons; E Rey; M O Richard; F Vauzelle; C Francoual; C Moran; P d'Athis; J Badoual; G Olive
Journal:  Dev Pharmacol Ther       Date:  1990

10.  Risk of selected postpartum infections after cesarean section compared with vaginal birth: a five-year cohort study of 32,468 women.

Authors:  Rita Andersen Leth; Jens Kjølseth Møller; Reimar Wernich Thomsen; Niels Uldbjerg; Mette Nørgaard
Journal:  Acta Obstet Gynecol Scand       Date:  2009-09       Impact factor: 3.636

View more
  1 in total

1.  Key Potentially Inappropriate Drugs in Pediatrics: The KIDs List.

Authors:  Rachel S Meyers; Jennifer Thackray; Kelly L Matson; Christopher McPherson; Lisa Lubsch; Robert C Hellinga; David S Hoff
Journal:  J Pediatr Pharmacol Ther       Date:  2020
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.